Literature DB >> 6437981

Antigenic S-type lipopolysaccharide of Brucella abortus 1119-3.

M Caroff, D R Bundle, M B Perry, J W Cherwonogrodzky, J R Duncan.   

Abstract

Antigenic phenol-phase soluble lipopolysaccharide isolated from Brucella abortus 1119-3 by hot phenol-water extraction was shown by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, controlled hydrolysis, periodate oxidation, methylation, and 1H and 13C nuclear magnetic resonance studies to be an S-type lipopolysaccharide which could be cleaved to yield a lipid A and an O-chain polysaccharide identified as an unbranched linear homopolymer of 1,2-linked 4,6-dideoxy-4-formamido-alpha-D-mannopyranosyl residues. The serological reactivity of bovine antiserum to B. abortus 1119-3 with the lipopolysaccharides of Yersinia enterocolitica serotype O:9 and Vibrio cholerae species has now been related to the occurrence of 1,2-linked N-acylated 4-amino-4,6-dideoxy-alpha-D-mannopyranosyl units in the O-chain polysaccharides of their lipopolysaccharides.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6437981      PMCID: PMC261543          DOI: 10.1128/iai.46.2.384-388.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  A RAPID PERMETHYLATION OF GLYCOLIPID, AND POLYSACCHARIDE CATALYZED BY METHYLSULFINYL CARBANION IN DIMETHYL SULFOXIDE.

Authors:  S HAKOMORI
Journal:  J Biochem       Date:  1964-02       Impact factor: 3.387

2.  A rapid procedure for the estimation of amino sugars on a micro scale.

Authors:  R Gatt; E R Berman
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

3.  Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus.

Authors:  E Moreno; M W Pitt; L M Jones; G G Schurig; D T Berman
Journal:  J Bacteriol       Date:  1979-05       Impact factor: 3.490

4.  Enzyme-linked immunosorbent assay for bovine immunoglobulin subclass-specific response to Brucella abortus lipopolysaccharides.

Authors:  V L Lamb; L M Jones; G G Schurig; D T Berman
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

5.  Surface antigens of smooth brucellae.

Authors:  R Diaz; L M Jones; D Leong; J B Wilson
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

6.  An enzyme-labelled immunosorbent assay for Brucella abortus antibodies.

Authors:  J T Magee
Journal:  J Med Microbiol       Date:  1980-02       Impact factor: 2.472

7.  Enzyme immunoassay of the antibody response to Brucella and Yersinia enterocolitica 09 infections in humans.

Authors:  A A Lindberg; S Haeggman; K Karlson; H E Carlsson; N S Mair
Journal:  J Hyg (Lond)       Date:  1982-04

8.  Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9.

Authors:  M Caroff; D R Bundle; M B Perry
Journal:  Eur J Biochem       Date:  1984-02-15

9.  The structure of the O-antigenic side chain of the lipopolysaccharide of Vibrio cholerae 569B (Inaba).

Authors:  J W Redmond
Journal:  Biochim Biophys Acta       Date:  1979-05-01

10.  Biological activities of Brucella abortus lipopolysaccharides.

Authors:  E Moreno; D T Berman; L A Boettcher
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

View more
  70 in total

1.  Increased sensitivity of the rapid hydrophobic grid membrane filter enzyme-labeled antibody procedure for Escherichia coli O157 detection in foods and bovine feces.

Authors:  R Szabo; E Todd; J MacKenzie; L Parrington; A Armstrong
Journal:  Appl Environ Microbiol       Date:  1990-11       Impact factor: 4.792

2.  Bovine brucellosis - diagnosis and eradication.

Authors:  B W Stemshorn
Journal:  Can Vet J       Date:  1985-01       Impact factor: 1.008

3.  Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication.

Authors:  J E Ugalde; C Czibener; M F Feldman; R A Ugalde
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Access to fluorescent probes via allyl glycosides: the synthesis of a Brucella trisaccharide epitope linked to a coumarin.

Authors:  E Eichler; J Kihlberg; D R Bundle
Journal:  Glycoconj J       Date:  1991-04       Impact factor: 2.916

5.  Characterization of smooth lipopolysaccharides and O polysaccharides of Brucella species by competition binding assays with monoclonal antibodies.

Authors:  V Weynants; D Gilson; A Cloeckaert; A Tibor; P A Denoel; F Godfroid; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

6.  Mechanism of Asp24 upregulation in Brucella abortus rough mutant with a disrupted O-antigen export system and effect of Asp24 in bacterial intracellular survival.

Authors:  Mingxing Tian; Jing Qu; Xiangan Han; Chan Ding; Shaohui Wang; Daxin Peng; Shengqing Yu
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

7.  Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils.

Authors:  O Rasool; E Freer; E Moreno; C Jarstrand
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines.

Authors:  J Goldstein; T Hoffman; C Frasch; E F Lizzio; P R Beining; D Hochstein; Y L Lee; R D Angus; B Golding
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Serological confirmation of Brucella abortus and Yersinia enterocolitica O:9 O-antigens by monoclonal antibodies.

Authors:  D R Bundle; M A Gidney; M B Perry; J R Duncan; J W Cherwonogrodzky
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  Serological patterns of brucellosis, leptospirosis and Q fever in Bos indicus cattle in Cameroon.

Authors:  Francesca Scolamacchia; Ian G Handel; Eric M Fèvre; Kenton L Morgan; Vincent N Tanya; Barend M de C Bronsvoort
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.